 This pilot study is a within-subject repeated measures design. This study will compare the neurophysiological and vascular responses to placebo and treatment with Lovaza omega-3-acid ethyl esters, Reliant Pharmaceuticals, Inc. in subjects with type 2 diabetes, neuropathy, and dyslipidemia. 